One of the primary driving forces in reprogramming cancer cell metabolism is the deregulated MYC family proto-oncogenes (MYC, MYCN, and MYCL) (Kalkat et al., 2017), which are known to encode master transcriptional factors that regulate metabolic gene expression. The gene discussed is MYC; the disease is cancer.